Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.47 |
| ▸ | ACE | P12821 | 2/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.40 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.40 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.35 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL69148 | 1.00 | MAPT (0.50) | MAPTPTGS2KDM4ETHRBALOX15 | |
| SCHEMBL197221 | 1.00 | MAPT (0.50) | MAPTPTGS2KDM4ETHRBALOX15 | |
| Ammonia Solution, Strong SCHEMBL19614510 | 0.98 | MAPT (0.48) | MAPTPTGS2KDM4ETHRBALOX15 | |
| Ammonia Solution, Strong SCHEMBL19614515 | 0.98 | MAPT (0.48) | MAPTPTGS2KDM4ETHRBALOX15 | |
| Cysteine SCHEMBL28399079 | 0.88 | PTGS1 (0.59) | MAPTPTGS2KDM4ETHRBALOX15 | |
| SCHEMBL929284 | 0.86 | ACE (0.56) | MAPTPTGS2KDM4ETHRBALOX15 | |
| SCHEMBL5904021 | 0.83 | — | — | |
| SCHEMBL4263217 | 0.83 | — | — | |
| SCHEMBL2284304 | 0.83 | — | — | |
| SCHEMBL7574384 | 0.82 | MAPT (0.42) | MAPTPTGS2KDM4ETHRBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2735 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122063207-A | Qualitative and quantitative detection method for mucolytic agent in biochemical reagent | 上海创化科技服务有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4734942-A1 | A PERSONAL CARE COMPOSITION COMPRISING A CARBOXYMETHYL CYSTEINE COMPOUND AND AN EXTRACT OF ENGELHARDTIA GENUS | Unilever IP Holdings B.V. (NL) | 2026-05-06 | — | — | EP | claimed |
| EP-4734934-A1 | PERSONAL CARE COMPOSITION BASED ON CARBOXYMETHYL CYSTEIN COMPOUND AND CAROTENOID OR ESTER THEREOF | Unilever IP Holdings B.V. (NL) | 2026-05-06 | — | — | EP | claimed |
| EP-4735119-A1 | A PERSONAL CARE COMPOSITION | Unilever IP Holdings B.V. (NL) | 2026-05-06 | — | — | EP | claimed |
| EP-4734947-A1 | A PERSONAL CARE COMPOSITION | Unilever IP Holdings B.V. (NL) | 2026-05-06 | — | — | EP | claimed |
| EP-4734943-A1 | PERSONAL CARE COMPOSITION COMPRISING A CARBOXYMETHYL CYSTEINE COMPOUND AND A SILYMARIN COMPOUND | Unilever IP Holdings B.V. (NL) | 2026-05-06 | — | — | EP | claimed |
| WO-2026087117-A1 | PERSONAL CARE COMPOSITION BASED ON CARBOXYMETHYL CYSTEINE COMPOUND AND ACETYL METHIONINE COMPOUND | UNILEVER IP HOLDINGS B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| EP-4615402-A1 | A PERSONAL CARE COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-09-17 | — | — | EP | claimed |
| EP-4615404-A1 | A PERSONAL CARE COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-09-17 | — | — | EP | claimed |
| EP-4615403-A1 | PERSONAL CARE COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-09-17 | — | — | EP | claimed |
| EP-0272462-A1 | Process for preparing ursodeoxycholic acid derivates and their inorganic and organic salts having therpeutic activity. | Jago Research AG (CH) | 1988-06-29 | — | — | EP | claimed |
| EP-0057489-B1 | THIOLIC DERIVATIVES OF ERYTHROMYCIN HAVING THERAPEUTIC ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | REFARMED, Recherches Pharmaceutiques et Médicales S.A. (CH) | 1986-11-12 | — | — | EP | claimed |
| EP-0144170-A1 | Biosynthesis of unnatural cephalosporins | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1985-06-12 | — | — | EP | claimed |
| EP-0143399-A2 | Cysteine derivatives, a process for their preparation, and pharmaceutical compostions which contain them | MAGIS FARMACEUTICI S.P.A. (IT) | 1985-06-05 | — | — | EP | claimed |
| US-4476120-A | ANTIBIOTICS | Sigma Tau Indistrie Farmaceutiche Riunites, p.A (IT) | 1984-10-09 | — | — | US | claimed |
| US-4387094-A | CARBOXYMETHYLCYSTEIN, COAGULATION OF CERVICAL MUCUS | LABORATORIES HUMAN-PHARM S.A. (FR) | 1983-06-07 | — | — | US | claimed |
| EP-0057489-A1 | Thiolic derivatives of erythromycin having therapeutic activity, process for their preparation and pharmaceutical compositions containing them | REFARMED, Recherches Pharmaceutiques et Médicales S.A. (CH) | 1982-08-11 | — | — | EP | claimed |
| US-4129593-A | Process for the production of high purity S-carboxymethyl-L-cysteine | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1978-12-12 | — | — | US | claimed |
| US-4054557-A | ISOLATION FROM MAMMALIAN BLOOD | AB KABI (SW) | 1977-10-18 | — | — | US | claimed |
| US-4002530-A | ACREMONIUM CULTURE | RECHERCHE ET INDUSTRIE THERAPEUTIQUES (R.I.T.) (BE) | 1977-01-11 | — | — | US | claimed |